RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I Think Managment Should Accept A Take-Over Offer of $50+I think thats pretty realistic. But a potential suitor will also be looking at all the scandal noise in the British news which throws bigger unknowns in the mix which may be a holdup as well. Potential price rollbacks to keep the peace, any delays in new product launches due to the loophole being exposed and Nhs asking doctors not to prescribe an Amco drug (which has already been reported as happening). I'd like to think brexit is the holdup, but hard not to think these other factors won't play a role. Any of these factors could potentially effect forward earnings guidance and we all seen Endo get halved revising guidance downward.
bull_man wrote: craigbad, i agree with you as to the "if they walk away, will cast doubts on what they found in the data room".....however, they haven't walked away yet (and apollo was most probably the highest bidder with the best package), which leads me to think that there remains conditions of some kind, either waiting for the CXR board review & approval, or waiting on the brexit vote (the recent polling is showing a 45% stay, 43% leave, and everyone knows that on voting day, the less riskiest side wins); i think we can pretty much throw out everyone's US$55.00 buyout, however a low $50's canadian makes sense on the fundamental side of things; if that doesn't happen, i'm thinking trading range around CDN$20's - CDN$30's until way after the U.S. election, and some sort of guidance from hilary as to her stance on this matter.